Clinical Trial Update: Defibrotide Dose-escalation for SOS Post-HSCT [Phase 2]

View source ↗

Summary

A phase 2 clinical trial is evaluating dose escalation of defibrotide for Sinusoidal Obstruction Syndrome/Veno-occlusive Disease after hematopoietic stem cell t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sinusoidal Obstruction Syndrome
• Veno-occlusive Disease

Drugs mentioned

• Defibrotide (defibrotide)

Snippet

Sponsor: New York Medical College | Conditions: Sinusoidal Obstruction Syndrome, Veno-occlusive Disease | Phase 2 | Status: RECRUITING